Skip to main content

Pharma Business & Marketing- Ehealth

















There are two basic classes of population from the point of pharmaceuticals view. The attitude of these two classes is so divergent that the behaviour which they display towards consumption of medicine is very different.These two classes are sufferers and non-sufferers. Sufferers tend to become hypochondriac and they ensure that they comply with the medicines while non-sufferers believe that nothing is wrong with them and perhaps will go wrong to their health till they cross the border of sufferers.


As demographics of India are creating a very powerful force for growth of every industry, pharma is not an exception. Healthy population as well as sick population is continuously getting updated on medical issues through Internet.


Now the population who consumes medicine whether it pharma or nutraceutical consists of both sick and healthy patients. They exhibit their behaviour of exhibiting their choice in selection of medicines. Coupled with Internet education and their awareness, they feel, they are making the right choice even in high involvement and high-risk products. As a result, they have created a new class of medical consumers.


Patient On-Chat ,Patient Online, Newsletters & Emails:


Out of almost 41 million people who are supposed to be diabetics in India, you will observe that hardly 4 million patients are taking adequate care of themselves through medicines while others might be taking care of their health through alternate medicines or other traditional methods. Having such vast gap between what can accrue through pharma industry what is not really creating in the market for the industry needs to be noticed by all marketers. What should my mind matters is intense and exhausted patient education. It's possible through patient communication.


The Question?- How to communicate with these learned medical consumers?


Answer: ADTC advertising and communication.


Points to keep in mind to make this an Effective Tool:




  1. Quality of product


  2. " Safety of product even at higher dosages


  3. " Continuous availability of information about the product


  4. " Continuous promotion of the product


  5. " Continuous credibility creation and continuous improvement of the product


Consumer looks into packaging, clear directions on label, safety instructions, warnings andother regulatory instructions. He also looks at price and competitive products. Besides, this he may look at bulk pack as one of his convenience if it's day-to-day purchase and consumption.



In order to develop specific action plan marketer needs to carry out following survey:Awareness, understanding existing use of any substitute or a competitor (may not be from the same category), buying patterns, usage and attitude patterns, trends of markets, regions, logistics and capacity to stock these products for different outlets.



PR ,Marketing and Communication Strategy:Pharmaceutical companies should have communication strategy besides main strategy.



sOME eXAMPLES:



Drugdiscoveryonline.com, pharmaceuticalonline.com are good with Newsletters.



SurveryRX is a web based platform that enables a company to conduct online medical market research with physicians across multiple sites in a secure environment.



Today's Featured one: Informed Horizons, LLC - Medical communications company committed to keeping physicians and patients up to date with the latest advances in pharmaceutical research.





Comments

Popular posts from this blog

Artificial Intelligence Policy and Governance in HEALTHCARE

  Artificial Intelligence has become the new frontier for digital transformation. Several  #digitalhealth  businesses of today rely on Machine Learning,  #AI  and other such technologies to make healthcare delivery more efficient and comprehensive. However, the efficient and responsible use of AI tools is an ongoing discussion and would mean culture, data management, technology shifts in the industry, and required up-grading and training professionals for better coordination. Hence, with the growing market potential and interest in AI, it is imperative to develop a thoughtthrough regulatory and legal framework on the adoption and use of AI. I have set forward a hypotheses to design a policy framework for AI technologies in my paper- "𝐀𝐫𝐭𝐢𝐟𝐢𝐜𝐢𝐚𝐥 𝐈𝐧𝐭𝐞𝐥𝐥𝐢𝐠𝐞𝐧𝐜𝐞 𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡 𝐏𝐨𝐥𝐢𝐜𝐲 – 𝐀 𝐆𝐥𝐨𝐛𝐚𝐥 𝐏𝐞𝐫𝐬𝐩𝐞𝐜𝐭𝐢𝐯𝐞" last year https://lnkd.in/emi3XWwa cited further by "𝐓𝐡𝐞 𝐐𝐮𝐚𝐧𝐝𝐚𝐫𝐲 𝐢𝐧 𝐃𝐚𝐭𝐚 𝐏𝐫𝐨𝐭𝐞𝐜𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐑

Artificial intelligence and Technology for Dentistry

Have you heard of this company  ORCA Dental AI ? ORCA combines clinical expertise with machine learning and AI technologies to create diagnostic reports, treatment plan suggestions and smart clinical predictions. Good to learn about these innovations that benefit every stakeholder in the value chain. Recently,  VideaHealth  raised $20M to Expand AI-Based Diagnostics led by Spark Capital including existing investors Zetta Venture Partners. Among its many benefits to dentists and patients are: – A 31% increase in diagnosis rate for cavities and 26% increase in treatment plan value; – An increase in case acceptance by patients due to second opinions; – Automated workflows accelerate treatment planning and charting; Another company touting AI-powered dental care and practice management is  Overjet , which announced a $42.5 million Series B funding round in December months after it had scored $27 million in Series A funding.  Pearl  provides AI for dental images to assist in diagnosis. It l

Big Data Analytics- The Microscope and Telescope for Pharma/CRO

This article is produced in consultation with Industry experts, and KOLs in India and across the world and especially highlights how “Predictive Analytics algorithms” are poised to provide Useful Analytics to the Pharma industry.   In today’s highly competitive market, it is extremely important for contract research and manufacturers to have access to information that allows them to target the specific segments of the pharmaceutical and biotechnology industry that are looking to outsource the particular services they provide.  Understanding shifts in annual outsourcing budgets and spending can help CROs and CMOs to better position themselves for capturing business, particularly at a time when many – if not all – pharma and biotech companies are looking to cut costs and streamline operations.  As per a recent report by NiceInsights, Analytical Services, Clinical Research, and Clinical Monitoring will be the most demanded services over the next 12 to 18 months. For CROs and CMOs looki